Pharmaceutical Business review

Watson gets FDA approval for generic pain drug

Watson’s oxycodone hydrochloride and ibuprofen product is the generic equivalent to Forest Laboratories’s Combunox, which is indicated for the short-term (not more than seven days) management of acute, moderate to severe pain.

Watson intends to launch its oxycodone hydrochloride and ibuprofen product immediately.